Clinical Trial Update: Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing the demyelination radiotracer [18F]3F4AP in healthy controls and individuals with Multiple Sclerosis. The study aims to evalu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• [18F]3F4AP

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Sclerosis | Phase 1 | Status: RECRUITING